Moreover, there has been a recent resurgence of interest in the mechanisms of hepatic EPO production (29) stimulated by the suggestion that hepatic EPO synthesis could replace the need for recombinant EPO administration in patients with anemia secondary to chronic kidney disease (30). Here, EPO is linked to anemia.